KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) EBIT Margin: 2009-2025

Historic EBIT Margin for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to -3.00%.

  • Exact Sciences' EBIT Margin rose 256.00% to -3.00% in Q3 2025 from the same period last year, while for Sep 2025 it was -32.45%, marking a year-over-year decrease of 2353.00%. This contributed to the annual value of -38.01% for FY2024, which is 2941.00% down from last year.
  • Per Exact Sciences' latest filing, its EBIT Margin stood at -3.00% for Q3 2025, which was down 1,033.81% from -0.26% recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' EBIT Margin registered a high of 1.09% during Q3 2023, and its lowest value of -122.84% during Q4 2024.
  • For the 3-year period, Exact Sciences' EBIT Margin averaged around -18.21%, with its median value being -10.49% (2023).
  • Its EBIT Margin has fluctuated over the past 5 years, first spiked by 4,225bps in 2021, then plummeted by 11,235bps in 2024.
  • Exact Sciences' EBIT Margin (Quarterly) stood at -46.74% in 2021, then soared by 2,524bps to -21.50% in 2022, then skyrocketed by 1,101bps to -10.49% in 2023, then tumbled by 11,235bps to -122.84% in 2024, then skyrocketed by 256bps to -3.00% in 2025.
  • Its EBIT Margin was -3.00% in Q3 2025, compared to -0.26% in Q2 2025 and -13.58% in Q1 2025.